Non-curative chemotherapy for cancer–is it worth it?
S Slater - Clinical Medicine, 2001 - ncbi.nlm.nih.gov
ClinMed13. 220to222 24/5/73 9: 39 am Page 220 patients with cancer, 68% would accept
chemo-therapy if it was likely that they would gain symptomatic control. A review in 1995 of …
chemo-therapy if it was likely that they would gain symptomatic control. A review in 1995 of …
Rationale for the treatment of non-small cell lung cancer
WK Evans - Lung cancer, 1993 - Elsevier
The vast numbers of patients with non-small cell lung cancer (NSCLC) worldwide deserve
more than the prevailing attitude of therapeutic nihilism. Although 5-year survival for all but …
more than the prevailing attitude of therapeutic nihilism. Although 5-year survival for all but …
Chemotherapy versus palliative care in non-small cell lung cancer
S Nicum, MH Cullen - Anti-Cancer Drugs, 2000 - journals.lww.com
Non-small cell lung cancer (NSCLC) is the world's leading cause of cancer death and about
75% of all patients have advanced disease incurable with localized treatments (surgery and …
75% of all patients have advanced disease incurable with localized treatments (surgery and …
New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
PA Bunn Jr, K Kelly - Clinical cancer research: an official journal of the …, 1998 - AACR
In past years, there has been considerable pessimism over the role of chemotherapy in non-
small cell lung cancers. The pessimism was largely derived from the fact that alkylating …
small cell lung cancers. The pessimism was largely derived from the fact that alkylating …
Further evidence in favour of chemotherapy for inoperable non-small cell lung cancer
G Buccheri, D Ferrigno, A Rosso, F Vola - Lung Cancer, 1990 - Elsevier
Recommendations concerning chemotherapy of patients of inoperable non-small cell lung
cancer (NSCLC) not included into protocols vary widely from the suggestion that 'no patient …
cancer (NSCLC) not included into protocols vary widely from the suggestion that 'no patient …
Chemotherapy in the management of patients with inoperable non-small cell lung cancer.
DN Carney - Seminars in oncology, 1996 - europepmc.org
Lung cancer remains a major epidemic problem worldwide. The majority of cases are
associated with cigarette smoking and the number of people who smoke continues to …
associated with cigarette smoking and the number of people who smoke continues to …
Chemotherapy or not in advanced non-small cell lung cancer?
R Cellerino, D Tummarello, A Piga - Lung Cancer, 1990 - Elsevier
The value of chemotherapy (CT) in patients with advanced non-small cell lung cancer
remains controversial. In the past 10 years results from 7 randomized studies of …
remains controversial. In the past 10 years results from 7 randomized studies of …
A brief historical review of the development of chemotherapy for the treatment of advanced non-small cell lung cancer: why we should look beyond platinum.
EM Bengtson, JR Rigas - Seminars in oncology, 1999 - europepmc.org
We are approaching the end of the fifth decade and the most productive period in the
development of chemotherapy for the treatment of advanced non-small cell lung cancer. We …
development of chemotherapy for the treatment of advanced non-small cell lung cancer. We …
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
E Rapp, JL Pater, A Willan, Y Cormier… - Journal of Clinical …, 1988 - ascopubs.org
The survival benefit of combination chemotherapy to patients with advanced non-small-cell
carcinoma of the lung (NSCLC) is controversial. To study this question, the National Cancer …
carcinoma of the lung (NSCLC) is controversial. To study this question, the National Cancer …
Chemotherapy for advanced lung cancer: When to expect a response
DE Midthun, JR Jett - Postgraduate medicine, 1997 - Taylor & Francis
PREVIEW Many patients with lung cancer have extensive, unresectable disease when the
diagnosis is first made, and long-term survival rates are poor. In this article, the authors …
diagnosis is first made, and long-term survival rates are poor. In this article, the authors …